Warning issued for mesotherapy, Lipodissolve, Lipostabil, and lipolysis
Looks as if the The American Society for Aesthetic Plastic Surgery (ASAPS) is coming hard on some very popular procedures that are being used by cosmetic surgeons but are still not endorsed by the association or approved by the FDA. For instance, lipolysis, mesotherapy (looks like so called spas and medspas are offering it to anyone who wants it), or the brand names Lipodissolve and Lipostabil.
Some of these procedures already approved and/or widely used overseas, it may take some time for the United States to catch up but it also means that crooks are active in this business. The procedures are sometimes being offered by persons without sufficient medical training, thereby putting patients at risk of harm.
Despite media and advertising claims that mesotherapy or injection lipolysis treatments can safely and effectively eliminate unwanted fat, published peer-reviewed scientific reports of properly performed controlled prospective trials to confirm either safety or efficacy do not exist. Furthermore, there is no objective data on how these treatments produce ‘fat dissolving‘ effects and there are numerous reports of complications documented in the medical literature, including bacterial infection, granulomas (disfiguring masses of chronically inflamed tissue) and localized necrosis (tissue death), particularly when injections were done by lay people.
According to Alan H. Gold, MD, president of the Aesthetic Surgery Education and Research Foundation (ASERF). “For now, the only proven method for eliminating unwanted fat cells is suction assisted lipoplasty (liposuction), a procedure that has a long and successful track record for both safety and effectiveness.”
There is an ongoing study to evaluate the effectiveness of mesotherapy but till then it is best to wait, according to ASAPS.
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.


Comments
No comments yet.
Sorry, the comment form is closed at this time.